{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "c95383dd-2187-401e-a4ee-0be38c25dd91",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1307\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Breast Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "82d29a4f-b165-49be-ac39-46c417a925ff",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2225\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Blood Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "db049a70-0f8b-4c86-95ed-0c293fe4e4db",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1071\n"
     ]
    }
   ],
   "source": [
    "\n",
    "c = 0\n",
    "for i in clTrials[\"Lung Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "b08c4ea0-fa71-43bf-b170-93578cb48be4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "419\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Colorectal Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "a16cd12f-5dec-4ec1-a186-689b5bb984eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "362\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Ovarian Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "e8035a06-957e-450a-a7f1-b577922e8e5f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "133\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Cervical Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "64e78283-7548-42bb-bae7-331407a07420",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "427\n"
     ]
    }
   ],
   "source": [
    "\n",
    "c = 0\n",
    "for i in clTrials[\"Melanoma Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "a1ef75b9-9ad0-472a-ad62-7b3049019caa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "359\n"
     ]
    }
   ],
   "source": [
    "c = 0\n",
    "for i in clTrials[\"Pancreatic Cancer\"]:\n",
    "    c= c+i\n",
    "print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "681285a9-d928-4229-a1ef-5e84a1db17d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from collections import Counter\n",
    "import matplotlib.pyplot as plt\n",
    "from seaborn import set_style\n",
    "\n",
    "set_style(\"whitegrid\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "4666920a-068d-4e88-a08e-b02910f3b4f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "clTrials = pd.read_csv(\"CancerClinicalTrialData.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "03349d76-ed5b-4749-bcec-3ce45d3bb9b2",
   "metadata": {},
   "outputs": [],
   "source": [
    "def check_breast_substring(x):\n",
    "    if \"Breast\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_blood_substring(x):\n",
    "    if \"Leukemia\" in x:\n",
    "        return 1\n",
    "    elif \"Lymphoma\" in x:\n",
    "        return 1\n",
    "    elif \"Myeloma\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_lung_substring(x):\n",
    "    if \"Lung\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_colorectal_substring(x):\n",
    "    if \"Colorectal\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_ovarian_substring(x):\n",
    "    if \"Ovarian\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_cervical_substring(x):\n",
    "    if \"Cervical\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "    \n",
    "def check_melanoma_substring(x):\n",
    "    if \"Melanoma\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "    \n",
    "def check_pancreatic_substring(x):\n",
    "    if \"Pancreatic\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_treatment_substring(x):\n",
    "    if \"Treatment\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_industry_substring(x):\n",
    "    if \"Industry\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0\n",
    "def check_fed_substring(x):\n",
    "    if \"Fed\" in x:\n",
    "        return 1\n",
    "    elif \"NIH\" in x:\n",
    "        return 1\n",
    "    else:\n",
    "        return 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "3d500966-78fd-486b-a6fd-62b99bbdb623",
   "metadata": {},
   "outputs": [],
   "source": [
    "clTrials[\"Breast Cancer\"] = clTrials[\"Conditions\"].apply(check_breast_substring)\n",
    "clTrials[\"Blood Cancer\"] = clTrials[\"Conditions\"].apply(check_blood_substring)\n",
    "clTrials[\"Lung Cancer\"] = clTrials[\"Conditions\"].apply(check_lung_substring)\n",
    "clTrials[\"Colorectal Cancer\"] = clTrials[\"Conditions\"].apply(check_colorectal_substring)\n",
    "clTrials[\"Ovarian Cancer\"] = clTrials[\"Conditions\"].apply(check_ovarian_substring)\n",
    "clTrials[\"Cervical Cancer\"] = clTrials[\"Conditions\"].apply(check_cervical_substring)\n",
    "clTrials[\"Melanoma Cancer\"] = clTrials[\"Conditions\"].apply(check_melanoma_substring)\n",
    "clTrials[\"Pancreatic Cancer\"] = clTrials[\"Conditions\"].apply(check_pancreatic_substring)\n",
    "clTrials['Study Designs'] = clTrials['Study Designs'].astype('str')\n",
    "clTrials[\"Treatment (Purpose)\"] = clTrials[\"Study Designs\"].apply(check_treatment_substring)\n",
    "clTrials[\"Fed Funding\"] = clTrials[\"Funded Bys\"].apply(check_industry_substring)\n",
    "clTrials[\"Industry Funding\"] = clTrials[\"Funded Bys\"].apply(check_fed_substring)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "42ef8b89-3d2d-4cbf-a159-12337d82533c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "621\n",
      "1604\n"
     ]
    }
   ],
   "source": [
    "# compare number of terminated and completed trials for blood cancer\n",
    "term = 0\n",
    "comp = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            comp = comp + 1\n",
    "        else:\n",
    "            term = term +1\n",
    "print(term)\n",
    "print(comp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "a23954d0-52ca-43b6-8960-b9b1f27799f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "883\n"
     ]
    }
   ],
   "source": [
    "gov_completed_bloodcancer=0\n",
    "ind_completed_bloodcancer=0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            if clTrials['Fed Funding'][i]==1:\n",
    "                gov_completed_bloodcancer += 1\n",
    "print(gov_completed_bloodcancer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "f788c2d4-d670-4b5f-8d4c-2e2b1ae52d38",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "453\n"
     ]
    }
   ],
   "source": [
    "ind_completed_bloodcancer=0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            if clTrials['Industry Funding'][i]==1:\n",
    "                ind_completed_bloodcancer += 1\n",
    "print(ind_completed_bloodcancer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "a7c3cc5f-e428-4da0-a5a0-4192f01d5ae9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "74.28428927680798\n"
     ]
    }
   ],
   "source": [
    "# Avertage duration of completed ones for blood cancer\n",
    "total_duration = 0\n",
    "c=0\n",
    "for i in range(len(clTrials['Status'])): #nothing special about status here.\n",
    "        if clTrials[\"Blood Cancer\"][i]==1:\n",
    "                if clTrials['Status'][i] == 'Completed':\n",
    "                    c = c+1\n",
    "                    total_duration += clTrials['Study Duration (months)'][i]\n",
    "average_duration_completed_blood = total_duration /c\n",
    "print(average_duration_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "502a645a-e605-41b1-90c1-b2334d497718",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "44.88083735909823\n"
     ]
    }
   ],
   "source": [
    "# Avertage duration of non-completed ones for blood cancer\n",
    "total_duration = 0\n",
    "c=0\n",
    "for i in range(len(clTrials['Status'])): #nothing special about status here.\n",
    "        if clTrials[\"Blood Cancer\"][i]==1:\n",
    "                if clTrials['Status'][i] != 'Completed':\n",
    "                    c = c+1\n",
    "                    total_duration += clTrials['Study Duration (months)'][i]\n",
    "average_duration_completed_blood = total_duration /c\n",
    "print(average_duration_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "a99fb1ca-07db-4a63-b167-c5212714e017",
   "metadata": {},
   "outputs": [],
   "source": [
    "Alloc =[]\n",
    "Interv = []\n",
    "Mask = []\n",
    "Purp = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "28ead07e-badf-494e-b748-6408d20bb818",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Seperate the allocation info from Study Desings\n",
    "def create_alloc():\n",
    "    for item in clTrials['Study Designs']:\n",
    "        if isinstance(item, str):\n",
    "            if 'Allocation' in item:\n",
    "                Alloc_splitted = item.split('Allocation: ')\n",
    "                Alloc_splitted_more = Alloc_splitted[1].split('|')\n",
    "                Alloc.append(Alloc_splitted_more[0])\n",
    "            else:\n",
    "                Alloc.append('N/A')\n",
    "        else: \n",
    "            Alloc.append('N/A')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "f14e3d29-4d39-45e3-81e3-6fb255648386",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Seperate the allocation info from Study Desings\n",
    "\n",
    "def create_interv():\n",
    "    for item in clTrials['Study Designs']:\n",
    "        if isinstance(item, str):\n",
    "            if 'Intervention Model' in item:\n",
    "                Interv_splitted = item.split('Intervention Model: ')\n",
    "                Interv_splitted_more = Interv_splitted[1].split('|')\n",
    "                Interv.append(Interv_splitted_more[0])\n",
    "            else:\n",
    "                Interv.append('N/A')\n",
    "        else: \n",
    "            Interv.append('N/A')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "c6168f86-8705-4572-aaad-94212f1c449d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_mask():\n",
    "    for item in clTrials['Study Designs']:\n",
    "        if isinstance(item, str):\n",
    "            if 'Masking' in item:\n",
    "                Mask_splitted = item.split('Masking: ')\n",
    "                Mask_splitted_more = Mask_splitted[1].split('|')\n",
    "                Mask.append(Mask_splitted_more[0])\n",
    "            else:\n",
    "                Mask.append('N/A')\n",
    "        else: \n",
    "            Mask.append('N/A')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "e42a9a77-7e45-4d97-9a42-ed600048f257",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_purp():\n",
    "    for item in clTrials['Study Designs']:\n",
    "        if isinstance(item, str):\n",
    "            if 'Primary Purpose' in item:\n",
    "                Purp_splitted = item.split('Primary Purpose: ')\n",
    "                Purp_splitted_more = Purp_splitted[1].split('|')\n",
    "                Purp.append(Purp_splitted_more[0])\n",
    "            else:\n",
    "                Purp.append('N/A')\n",
    "        else: \n",
    "            Purp.append('N/A')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "6161934b-97f4-4423-be8e-6008c82b4603",
   "metadata": {},
   "outputs": [],
   "source": [
    "create_alloc()\n",
    "create_interv()\n",
    "create_mask()\n",
    "create_purp()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "e5bfdc53-42c9-4e5e-a33e-a6f70f5b07e3",
   "metadata": {},
   "outputs": [],
   "source": [
    "clTrials['Allocations'] = Alloc\n",
    "clTrials['Intervention Model'] = Interv\n",
    "clTrials['Maksing'] = Mask\n",
    "clTrials['Primary Purpose'] = Purp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "1da435e9-2e2c-4a20-aab6-33695ccc1379",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Cervical Cancer</th>\n",
       "      <th>Melanoma Cancer</th>\n",
       "      <th>Pancreatic Cancer</th>\n",
       "      <th>Treatment (Purpose)</th>\n",
       "      <th>Fed Funding</th>\n",
       "      <th>Industry Funding</th>\n",
       "      <th>Allocations</th>\n",
       "      <th>Intervention Model</th>\n",
       "      <th>Maksing</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Immediate-Release Oxycodone Capsules Study in ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Oxycodone|Drug: Morphine</td>\n",
       "      <td>Numerical Rating Scale (NRS)|The Average Dose ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 80 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>A Phase II Study of Nivolumab in Combination W...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Drug: Nivolumab|Drug: Cabozantinib</td>\n",
       "      <td>Overall Response Rate|Number of Participants W...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Radiation, Cetuximab and Pemetrexed With or Wi...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Bevacizumab|Drug: Cetuximab|Drug: Pemetr...</td>\n",
       "      <td>2-year Progression-free Survival (PFS)|2-year ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Diagnostic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Fulvestrant Plus Enzalutamide in ER+/Her2- Adv...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Drug: Fulvestrant with Enzalutamide</td>\n",
       "      <td>Clinical Benefit Rate of the Combination of En...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 100 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>PROspective Non-interventional Open laBEl Tria...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Oxycodone/Naloxone</td>\n",
       "      <td>Change in Numeric Rating Scales (NRS) Score|Ch...</td>\n",
       "      <td>All</td>\n",
       "      <td>20 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11191</th>\n",
       "      <td>11192</td>\n",
       "      <td>Safety and Efficacy of ATIR101 as Adjunctive T...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Acute Myeloid Leukemia|Acute Lymphoblastic Leu...</td>\n",
       "      <td>Biological: ATIR101|Drug: Cyclophosphamide|Pro...</td>\n",
       "      <td>Graft-versus-host Disease-free, Relapse-free S...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Prevention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11192</th>\n",
       "      <td>11193</td>\n",
       "      <td>CD24Fc for the Treatment of Immune Related Adv...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Advanced Malignant Solid Neoplasm</td>\n",
       "      <td>Biological: CD24 Extracellular Domain-IgG1 Fc ...</td>\n",
       "      <td>Incidence of New Adverse Event (AE) of &gt;= Grad...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11193</th>\n",
       "      <td>11194</td>\n",
       "      <td>Immune Checkpoint Inhibitor M7824 and the Immu...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Histologically or Cytologically Confirmed Panc...</td>\n",
       "      <td>Drug: M7824|Drug: M9241|Radiation: SBRT</td>\n",
       "      <td>Recommended Phase 2 Dose (RP2D) of NHS-IL12 (M...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Sequential Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11194</th>\n",
       "      <td>11195</td>\n",
       "      <td>Study of Euthyroid Hypothyroxinemia in Metasta...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Metastatic Breast Cancer|Thyroid Dysfunction</td>\n",
       "      <td>Drug: Triiodothyronine (T3)</td>\n",
       "      <td>Number of Participants With Progression-free S...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 105 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11195</th>\n",
       "      <td>11196</td>\n",
       "      <td>A Phase 2 Study of Durvalumab in Combination W...</td>\n",
       "      <td>Suspended</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Mesothelioma</td>\n",
       "      <td>Drug: Tremelimumab|Drug: Durvalumab</td>\n",
       "      <td>Overall Response Rate|Overall Survival|Progres...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11196 rows × 33 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        Rank                                              Title      Status  \\\n",
       "0          1  Immediate-Release Oxycodone Capsules Study in ...   Completed   \n",
       "1          2  A Phase II Study of Nivolumab in Combination W...   Completed   \n",
       "2          3  Radiation, Cetuximab and Pemetrexed With or Wi...   Completed   \n",
       "3          4  Fulvestrant Plus Enzalutamide in ER+/Her2- Adv...   Completed   \n",
       "4          5  PROspective Non-interventional Open laBEl Tria...   Completed   \n",
       "...      ...                                                ...         ...   \n",
       "11191  11192  Safety and Efficacy of ATIR101 as Adjunctive T...  Terminated   \n",
       "11192  11193  CD24Fc for the Treatment of Immune Related Adv...  Terminated   \n",
       "11193  11194  Immune Checkpoint Inhibitor M7824 and the Immu...  Terminated   \n",
       "11194  11195  Study of Euthyroid Hypothyroxinemia in Metasta...  Terminated   \n",
       "11195  11196  A Phase 2 Study of Durvalumab in Combination W...   Suspended   \n",
       "\n",
       "      Study Results                                         Conditions  \\\n",
       "0       Has Results                                             Cancer   \n",
       "1       Has Results                                      Breast Cancer   \n",
       "2       Has Results                                             Cancer   \n",
       "3       Has Results                                      Breast Cancer   \n",
       "4       Has Results                                             Cancer   \n",
       "...             ...                                                ...   \n",
       "11191   Has Results  Acute Myeloid Leukemia|Acute Lymphoblastic Leu...   \n",
       "11192   Has Results                  Advanced Malignant Solid Neoplasm   \n",
       "11193   Has Results  Histologically or Cytologically Confirmed Panc...   \n",
       "11194   Has Results       Metastatic Breast Cancer|Thyroid Dysfunction   \n",
       "11195   Has Results                                       Mesothelioma   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                         Drug: Oxycodone|Drug: Morphine   \n",
       "1                     Drug: Nivolumab|Drug: Cabozantinib   \n",
       "2      Drug: Bevacizumab|Drug: Cetuximab|Drug: Pemetr...   \n",
       "3                    Drug: Fulvestrant with Enzalutamide   \n",
       "4                               Drug: Oxycodone/Naloxone   \n",
       "...                                                  ...   \n",
       "11191  Biological: ATIR101|Drug: Cyclophosphamide|Pro...   \n",
       "11192  Biological: CD24 Extracellular Domain-IgG1 Fc ...   \n",
       "11193            Drug: M7824|Drug: M9241|Radiation: SBRT   \n",
       "11194                        Drug: Triiodothyronine (T3)   \n",
       "11195                Drug: Tremelimumab|Drug: Durvalumab   \n",
       "\n",
       "                                        Outcome Measures  Gender  \\\n",
       "0      Numerical Rating Scale (NRS)|The Average Dose ...     All   \n",
       "1      Overall Response Rate|Number of Participants W...  Female   \n",
       "2      2-year Progression-free Survival (PFS)|2-year ...     All   \n",
       "3      Clinical Benefit Rate of the Combination of En...  Female   \n",
       "4      Change in Numeric Rating Scales (NRS) Score|Ch...     All   \n",
       "...                                                  ...     ...   \n",
       "11191  Graft-versus-host Disease-free, Relapse-free S...     All   \n",
       "11192  Incidence of New Adverse Event (AE) of >= Grad...     All   \n",
       "11193  Recommended Phase 2 Dose (RP2D) of NHS-IL12 (M...     All   \n",
       "11194  Number of Participants With Progression-free S...     All   \n",
       "11195  Overall Response Rate|Overall Survival|Progres...     All   \n",
       "\n",
       "                                                Age           Phases  ...  \\\n",
       "0       18 Years to 80 Years   (Adult, Older Adult)          Phase 3  ...   \n",
       "1         18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "2         18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "3      18 Years to 100 Years   (Adult, Older Adult)          Phase 2  ...   \n",
       "4         20 Years and older   (Adult, Older Adult)          Phase 4  ...   \n",
       "...                                             ...              ...  ...   \n",
       "11191   18 Years to 70 Years   (Adult, Older Adult)          Phase 3  ...   \n",
       "11192     18 Years and older   (Adult, Older Adult)  Phase 1|Phase 2  ...   \n",
       "11193     18 Years and older   (Adult, Older Adult)  Phase 1|Phase 2  ...   \n",
       "11194  18 Years to 105 Years   (Adult, Older Adult)          Phase 2  ...   \n",
       "11195     18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "\n",
       "       Cervical Cancer Melanoma Cancer Pancreatic Cancer Treatment (Purpose)  \\\n",
       "0                    0               0                 0                   1   \n",
       "1                    0               0                 0                   1   \n",
       "2                    0               0                 0                   0   \n",
       "3                    0               0                 0                   1   \n",
       "4                    0               0                 0                   1   \n",
       "...                ...             ...               ...                 ...   \n",
       "11191                0               0                 0                   0   \n",
       "11192                0               0                 0                   1   \n",
       "11193                0               0                 1                   1   \n",
       "11194                0               0                 0                   1   \n",
       "11195                0               0                 0                   1   \n",
       "\n",
       "      Fed Funding  Industry Funding     Allocations       Intervention Model  \\\n",
       "0               1                 0      Randomized      Parallel Assignment   \n",
       "1               1                 0             N/A  Single Group Assignment   \n",
       "2               1                 0      Randomized  Single Group Assignment   \n",
       "3               0                 1             N/A  Single Group Assignment   \n",
       "4               1                 0             N/A  Single Group Assignment   \n",
       "...           ...               ...             ...                      ...   \n",
       "11191           1                 0      Randomized      Parallel Assignment   \n",
       "11192           1                 1      Randomized      Parallel Assignment   \n",
       "11193           0                 1  Non-Randomized    Sequential Assignment   \n",
       "11194           0                 0             N/A  Single Group Assignment   \n",
       "11195           1                 0             N/A  Single Group Assignment   \n",
       "\n",
       "                                                 Maksing  Primary Purpose  \n",
       "0      Quadruple (Participant, Care Provider, Investi...        Treatment  \n",
       "1                                      None (Open Label)        Treatment  \n",
       "2                                      None (Open Label)       Diagnostic  \n",
       "3                                      None (Open Label)        Treatment  \n",
       "4                                      None (Open Label)        Treatment  \n",
       "...                                                  ...              ...  \n",
       "11191                                  None (Open Label)       Prevention  \n",
       "11192                 Double (Participant, Investigator)        Treatment  \n",
       "11193                                  None (Open Label)        Treatment  \n",
       "11194                                  None (Open Label)        Treatment  \n",
       "11195                                  None (Open Label)        Treatment  \n",
       "\n",
       "[11196 rows x 33 columns]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clTrials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "3cac0a1d-7e2c-4f59-ae31-55df100b1503",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "383\n",
      "1604\n",
      "0.2387780548628429\n"
     ]
    }
   ],
   "source": [
    "completed_randomized_blood=0\n",
    "completed_total_blood =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_total_blood += 1\n",
    "            if clTrials['Allocations'][i]=='Randomized':\n",
    "                completed_randomized_blood += 1\n",
    "print(completed_randomized_blood)\n",
    "print(completed_total_blood)\n",
    "print(completed_randomized_blood/completed_total_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "a8c0a551-6b16-4f28-a624-a5b9b37a3b19",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "307\n",
      "1604\n",
      "0.19139650872817954\n"
     ]
    }
   ],
   "source": [
    "completed_nonrandomized_blood=0\n",
    "completed_total_blood =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_total_blood += 1\n",
    "            if clTrials['Allocations'][i]=='Non-Randomized':\n",
    "                completed_nonrandomized_blood += 1\n",
    "print(completed_nonrandomized_blood)\n",
    "print(completed_total_blood)\n",
    "print(completed_nonrandomized_blood/completed_total_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "b50029d2-ecfb-416a-b537-2a8f38994326",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "914\n",
      "1604\n",
      "0.5698254364089775\n"
     ]
    }
   ],
   "source": [
    "completed_na_blood=0\n",
    "completed_total_blood =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_total_blood += 1\n",
    "            if clTrials['Allocations'][i]=='N/A':\n",
    "                completed_na_blood += 1\n",
    "print(completed_na_blood)\n",
    "print(completed_total_blood)\n",
    "print(completed_na_blood/completed_total_blood)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e59f1c8c-f079-469b-b78d-2677f4c48d4b",
   "metadata": {},
   "source": [
    "Conclusion: For more than half of the completed blood cancer trials, Allocation is N/A"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "122dc633-ba7d-4538-addd-178a495b2b12",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "379\n",
      "621\n",
      "0.6103059581320451\n"
     ]
    }
   ],
   "source": [
    "not_completed_na_blood=0\n",
    "not_completed_total_blood =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] != 'Completed':\n",
    "            not_completed_total_blood += 1\n",
    "            if clTrials['Allocations'][i]=='N/A':\n",
    "                not_completed_na_blood += 1\n",
    "print(not_completed_na_blood)\n",
    "print(not_completed_total_blood)\n",
    "print(not_completed_na_blood/not_completed_total_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "09dc90e3-4408-4524-a12a-fb57160ec1eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "156\n",
      "312\n",
      "0.5\n"
     ]
    }
   ],
   "source": [
    "not_completed_na_breast=0\n",
    "not_completed_total_breast =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Breast Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] != 'Completed':\n",
    "            not_completed_total_breast += 1\n",
    "            if clTrials['Allocations'][i]=='N/A':\n",
    "                not_completed_na_breast += 1\n",
    "print(not_completed_na_breast)\n",
    "print(not_completed_total_breast)\n",
    "print(not_completed_na_breast/not_completed_total_breast)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "54543559-15d3-4cf2-8cb3-404afcb5746f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "389\n",
      "995\n",
      "0.39095477386934674\n"
     ]
    }
   ],
   "source": [
    "completed_na_breast=0\n",
    "completed_total_breast =0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Breast Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_total_breast += 1\n",
    "            if clTrials['Allocations'][i]=='N/A':\n",
    "                completed_na_breast += 1\n",
    "print(completed_na_breast)\n",
    "print(completed_total_breast)\n",
    "print(completed_na_breast/completed_total_breast)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "967f361e-3955-4cde-8f43-bfb5cad996fb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "179601 1604 21050 621\n",
      "111.9706982543641 33.89694041867955\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted blood cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Blood Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "391fca14-7b8a-4287-bbc0-bbb34f91bde0",
   "metadata": {},
   "source": [
    "There is a remarkable difference in the average number of enrollments (completed vs notcompleted)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "56ccd633-2b5d-4430-9360-2d9f0a7f53cd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "303246 995 16750 312\n",
      "304.76984924623116 53.68589743589744\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted breast cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Breast Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2b63608e-aeff-4649-a742-f5ddb2d20e1d",
   "metadata": {},
   "source": [
    "There is a remarkable difference in the average number of enrollments (completed vs notcompleted)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "50c18f1c-95d3-4bb3-9d39-ab20cbca414f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "201624 784 17879 287\n",
      "257.1734693877551 62.29616724738676\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted lung cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Lung Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "44d3f7c4-6f7f-493d-9ed1-e6b050f8ae6a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "178937 333 6708 86\n",
      "537.3483483483484 78.0\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted Colorectal cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Colorectal Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "89e156e3-a735-42b8-aea1-54bf4be9f0be",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "32770 276 3813 86\n",
      "118.73188405797102 44.33720930232558\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted Ovarian cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Ovarian Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "65e848e2-86f9-43b3-b4a0-dfb57ce6a039",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "126835 103 7831 30\n",
      "1231.4077669902913 261.03333333333336\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted Cervical cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Cervical Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "bd57fda5-84a7-4542-8e44-b8569a148651",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "60867 295 4840 132\n",
      "206.32881355932204 36.666666666666664\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted Melanoma cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Melanoma Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "4cc96ffe-cddb-4f6d-b213-d9dcc1f7093d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "26056 257 3179 102\n",
      "101.3852140077821 31.166666666666668\n"
     ]
    }
   ],
   "source": [
    "# Average enrollments for completed vs noncompleted Pancreatic cancer trials.\n",
    "completed_blood_enrollment=0\n",
    "completed_blood = 0\n",
    "not_completed_blood_enrollment =0\n",
    "not_completed_blood = 0\n",
    "for i in range(len(clTrials['Status'])):\n",
    "    if clTrials[\"Pancreatic Cancer\"][i]==1:\n",
    "        if clTrials['Status'][i] == 'Completed':\n",
    "            completed_blood += 1\n",
    "            completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "        else:\n",
    "            not_completed_blood += 1\n",
    "            not_completed_blood_enrollment += clTrials['Enrollment'][i]\n",
    "\n",
    "print(completed_blood_enrollment, completed_blood, not_completed_blood_enrollment, not_completed_blood)\n",
    "print(completed_blood_enrollment/completed_blood, not_completed_blood_enrollment/not_completed_blood)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "920545e9-ad31-41be-bbdb-3f00a52ec036",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ce65dbf6-d600-456d-8f47-2850fd4678f0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fce3bd27-8056-4a94-b4f8-25017d5bf2da",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "c8ea0b0e-6f37-46cb-895b-59dc9352aaa8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Blood Cancer</th>\n",
       "      <th>Lung Cancer</th>\n",
       "      <th>Colorectal Cancer</th>\n",
       "      <th>Ovarian Cancer</th>\n",
       "      <th>Cervical Cancer</th>\n",
       "      <th>Melanoma Cancer</th>\n",
       "      <th>Pancreatic Cancer</th>\n",
       "      <th>Treatment (Purpose)</th>\n",
       "      <th>Fed Funding</th>\n",
       "      <th>Industry Funding</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Immediate-Release Oxycodone Capsules Study in ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Oxycodone|Drug: Morphine</td>\n",
       "      <td>Numerical Rating Scale (NRS)|The Average Dose ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 80 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>A Phase II Study of Nivolumab in Combination W...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Drug: Nivolumab|Drug: Cabozantinib</td>\n",
       "      <td>Overall Response Rate|Number of Participants W...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>Radiation, Cetuximab and Pemetrexed With or Wi...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Bevacizumab|Drug: Cetuximab|Drug: Pemetr...</td>\n",
       "      <td>2-year Progression-free Survival (PFS)|2-year ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Fulvestrant Plus Enzalutamide in ER+/Her2- Adv...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Drug: Fulvestrant with Enzalutamide</td>\n",
       "      <td>Clinical Benefit Rate of the Combination of En...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 100 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>PROspective Non-interventional Open laBEl Tria...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: Oxycodone/Naloxone</td>\n",
       "      <td>Change in Numeric Rating Scales (NRS) Score|Ch...</td>\n",
       "      <td>All</td>\n",
       "      <td>20 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11191</th>\n",
       "      <td>11192</td>\n",
       "      <td>Safety and Efficacy of ATIR101 as Adjunctive T...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Acute Myeloid Leukemia|Acute Lymphoblastic Leu...</td>\n",
       "      <td>Biological: ATIR101|Drug: Cyclophosphamide|Pro...</td>\n",
       "      <td>Graft-versus-host Disease-free, Relapse-free S...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11192</th>\n",
       "      <td>11193</td>\n",
       "      <td>CD24Fc for the Treatment of Immune Related Adv...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Advanced Malignant Solid Neoplasm</td>\n",
       "      <td>Biological: CD24 Extracellular Domain-IgG1 Fc ...</td>\n",
       "      <td>Incidence of New Adverse Event (AE) of &gt;= Grad...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11193</th>\n",
       "      <td>11194</td>\n",
       "      <td>Immune Checkpoint Inhibitor M7824 and the Immu...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Histologically or Cytologically Confirmed Panc...</td>\n",
       "      <td>Drug: M7824|Drug: M9241|Radiation: SBRT</td>\n",
       "      <td>Recommended Phase 2 Dose (RP2D) of NHS-IL12 (M...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11194</th>\n",
       "      <td>11195</td>\n",
       "      <td>Study of Euthyroid Hypothyroxinemia in Metasta...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Metastatic Breast Cancer|Thyroid Dysfunction</td>\n",
       "      <td>Drug: Triiodothyronine (T3)</td>\n",
       "      <td>Number of Participants With Progression-free S...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 105 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11195</th>\n",
       "      <td>11196</td>\n",
       "      <td>A Phase 2 Study of Durvalumab in Combination W...</td>\n",
       "      <td>Suspended</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Mesothelioma</td>\n",
       "      <td>Drug: Tremelimumab|Drug: Durvalumab</td>\n",
       "      <td>Overall Response Rate|Overall Survival|Progres...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11196 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        Rank                                              Title      Status  \\\n",
       "0          1  Immediate-Release Oxycodone Capsules Study in ...   Completed   \n",
       "1          2  A Phase II Study of Nivolumab in Combination W...   Completed   \n",
       "2          3  Radiation, Cetuximab and Pemetrexed With or Wi...   Completed   \n",
       "3          4  Fulvestrant Plus Enzalutamide in ER+/Her2- Adv...   Completed   \n",
       "4          5  PROspective Non-interventional Open laBEl Tria...   Completed   \n",
       "...      ...                                                ...         ...   \n",
       "11191  11192  Safety and Efficacy of ATIR101 as Adjunctive T...  Terminated   \n",
       "11192  11193  CD24Fc for the Treatment of Immune Related Adv...  Terminated   \n",
       "11193  11194  Immune Checkpoint Inhibitor M7824 and the Immu...  Terminated   \n",
       "11194  11195  Study of Euthyroid Hypothyroxinemia in Metasta...  Terminated   \n",
       "11195  11196  A Phase 2 Study of Durvalumab in Combination W...   Suspended   \n",
       "\n",
       "      Study Results                                         Conditions  \\\n",
       "0       Has Results                                             Cancer   \n",
       "1       Has Results                                      Breast Cancer   \n",
       "2       Has Results                                             Cancer   \n",
       "3       Has Results                                      Breast Cancer   \n",
       "4       Has Results                                             Cancer   \n",
       "...             ...                                                ...   \n",
       "11191   Has Results  Acute Myeloid Leukemia|Acute Lymphoblastic Leu...   \n",
       "11192   Has Results                  Advanced Malignant Solid Neoplasm   \n",
       "11193   Has Results  Histologically or Cytologically Confirmed Panc...   \n",
       "11194   Has Results       Metastatic Breast Cancer|Thyroid Dysfunction   \n",
       "11195   Has Results                                       Mesothelioma   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                         Drug: Oxycodone|Drug: Morphine   \n",
       "1                     Drug: Nivolumab|Drug: Cabozantinib   \n",
       "2      Drug: Bevacizumab|Drug: Cetuximab|Drug: Pemetr...   \n",
       "3                    Drug: Fulvestrant with Enzalutamide   \n",
       "4                               Drug: Oxycodone/Naloxone   \n",
       "...                                                  ...   \n",
       "11191  Biological: ATIR101|Drug: Cyclophosphamide|Pro...   \n",
       "11192  Biological: CD24 Extracellular Domain-IgG1 Fc ...   \n",
       "11193            Drug: M7824|Drug: M9241|Radiation: SBRT   \n",
       "11194                        Drug: Triiodothyronine (T3)   \n",
       "11195                Drug: Tremelimumab|Drug: Durvalumab   \n",
       "\n",
       "                                        Outcome Measures  Gender  \\\n",
       "0      Numerical Rating Scale (NRS)|The Average Dose ...     All   \n",
       "1      Overall Response Rate|Number of Participants W...  Female   \n",
       "2      2-year Progression-free Survival (PFS)|2-year ...     All   \n",
       "3      Clinical Benefit Rate of the Combination of En...  Female   \n",
       "4      Change in Numeric Rating Scales (NRS) Score|Ch...     All   \n",
       "...                                                  ...     ...   \n",
       "11191  Graft-versus-host Disease-free, Relapse-free S...     All   \n",
       "11192  Incidence of New Adverse Event (AE) of >= Grad...     All   \n",
       "11193  Recommended Phase 2 Dose (RP2D) of NHS-IL12 (M...     All   \n",
       "11194  Number of Participants With Progression-free S...     All   \n",
       "11195  Overall Response Rate|Overall Survival|Progres...     All   \n",
       "\n",
       "                                                Age           Phases  ...  \\\n",
       "0       18 Years to 80 Years   (Adult, Older Adult)          Phase 3  ...   \n",
       "1         18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "2         18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "3      18 Years to 100 Years   (Adult, Older Adult)          Phase 2  ...   \n",
       "4         20 Years and older   (Adult, Older Adult)          Phase 4  ...   \n",
       "...                                             ...              ...  ...   \n",
       "11191   18 Years to 70 Years   (Adult, Older Adult)          Phase 3  ...   \n",
       "11192     18 Years and older   (Adult, Older Adult)  Phase 1|Phase 2  ...   \n",
       "11193     18 Years and older   (Adult, Older Adult)  Phase 1|Phase 2  ...   \n",
       "11194  18 Years to 105 Years   (Adult, Older Adult)          Phase 2  ...   \n",
       "11195     18 Years and older   (Adult, Older Adult)          Phase 2  ...   \n",
       "\n",
       "       Blood Cancer Lung Cancer Colorectal Cancer Ovarian Cancer  \\\n",
       "0                 0           0                 0              0   \n",
       "1                 0           0                 0              0   \n",
       "2                 0           0                 0              0   \n",
       "3                 0           0                 0              0   \n",
       "4                 0           0                 0              0   \n",
       "...             ...         ...               ...            ...   \n",
       "11191             1           0                 0              0   \n",
       "11192             0           0                 0              0   \n",
       "11193             0           0                 0              0   \n",
       "11194             0           0                 0              0   \n",
       "11195             0           0                 0              0   \n",
       "\n",
       "      Cervical Cancer  Melanoma Cancer Pancreatic Cancer Treatment (Purpose)  \\\n",
       "0                   0                0                 0                   1   \n",
       "1                   0                0                 0                   1   \n",
       "2                   0                0                 0                   0   \n",
       "3                   0                0                 0                   1   \n",
       "4                   0                0                 0                   1   \n",
       "...               ...              ...               ...                 ...   \n",
       "11191               0                0                 0                   0   \n",
       "11192               0                0                 0                   1   \n",
       "11193               0                0                 1                   1   \n",
       "11194               0                0                 0                   1   \n",
       "11195               0                0                 0                   1   \n",
       "\n",
       "       Fed Funding  Industry Funding  \n",
       "0                1                 0  \n",
       "1                1                 0  \n",
       "2                1                 0  \n",
       "3                0                 1  \n",
       "4                1                 0  \n",
       "...            ...               ...  \n",
       "11191            1                 0  \n",
       "11192            1                 1  \n",
       "11193            0                 1  \n",
       "11194            0                 0  \n",
       "11195            1                 0  \n",
       "\n",
       "[11196 rows x 29 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clTrials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a93c6cc4-6cd5-483b-8e17-b33f865fe42d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
